The relative contribution of the CYP2C19*2 polymorphism in the low responsiveness to clopidogrel in the VASP-02 study

被引：0
|
作者：
Aleil, B. [1 ]
De Poli, F. [2 ]
Zaehringer, M. [1 ]
Collet, J. P. [3 ,4 ]
Montalescot, G. [3 ,4 ]
Leon, C. [5 ]
Cazenave, J. P. [5 ]
Dickele, M. C. [2 ]
Monassier, J. P. [6 ]
Gachet, C. [5 ]
机构：
[1] Clin Orangerie, Strasbourg, France
[2] Ctr Hosp Gen, Serv Cardiol, Haguenau, France
[3] Hop La Pitie Salpetriere, AP HP, Inst Cardiol, Paris, France
[4] Hop La Pitie Salpetriere, AP HP, INSERM, U856, Paris, France
[5] Univ Strasbourg, INSERM, UMR S 949, Etab Francais Sang Alsace, Strasbourg, France
[6] Hop Emile Muller, Serv Cardiol, Mulhouse, France
来源：
EUROPEAN HEART JOURNAL | 2009年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：327 / 328
页数：2
相关论文
共 50 条
  • [1] The relative contribution of the CYP2C19*2 polymorphism in the low responsiveness to clopidogrel in the VASP02 study
    Aleil, B.
    Jacquemin, L.
    De Poli, F.
    Zaehringer, M.
    Collet, J. P.
    Montalescot, G.
    Leon, C.
    Cazenave, J. P.
    Dickele, M. C.
    Monassier, J. P.
    Gachet, C.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 104 - 104
  • [2] CYP2C19*2 polymorphism and clopidogrel resistance
    Joob, Beuy
    Wiwanitkit, Viroj
    ARCHIVOS DE CARDIOLOGIA DE MEXICO, 2020, 90 (04): : 505 - 505
  • [3] CYP2C19 gene polymorphism and platelet responsiveness to clopidogrel in Korean patients with ischemic stroke
    Lee, H. C.
    Lee, B. C.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 880 - 880
  • [4] The effect of CYP2C19 and CYP2C9 polymorphism on the pharmacodynamics of clopidogrel
    Jiang, Juanjuan
    Tian, Lei
    Han, Lulu
    Yan, Yan
    Huang, Yiling
    Liu, Hong
    Xie, Shuang
    Li, Yishi
    CARDIOLOGY, 2011, 120 : 30 - 31
  • [5] The effect of CYP2C19*2 polymorphism on clopidogrel resistance in COPD patients
    Kilik, Zeliha Funda
    Akalin, Hilal
    Bayramov, Ruslan
    Erdem, Yakut
    Dundar, Munis
    JOURNAL OF BIOTECHNOLOGY, 2017, 256 : S80 - S80
  • [6] CYP2C19*2 polymorphism contributes to a diminished pharmacodynamic response to clopidogrel
    Brandt, JT
    Kirkwood, S
    Mukhopadhyay, N
    Payne, CD
    Salazar, D
    Ernest, CS
    Winters, KJ
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (04) : 380A - 380A
  • [7] The impact of CYP2C19 gene polymorphism on the antiplatelet effect of clopidogrel and ticlopidine; the efficacy of ticlopidine on the non-responders of clopidogrel with CYP2C19 gene polymorphism
    Ishiguro, H.
    Asai, T.
    Umemoto, N.
    Sumida, A.
    Shimizu, K.
    Murohara, T.
    Maeda, A.
    Ando, H.
    Fujimura, A.
    EUROPEAN HEART JOURNAL, 2010, 31 : 968 - 968
  • [8] The correlation between platelet responsiveness to clopidogrel and CYP2C19 polymorphism in patients with peripheral vascular disease
    El-Khodary, N. M.
    El-Behery, A. M.
    El-Askary, N. A.
    Donia, H. M.
    Omran, G. A.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2021, 25 (19) : 6065 - 6076
  • [9] The CYP2C19*2 and CYP2C19*17 Polymorphisms play a Vital Role in Clopidogrel Responsiveness after Percutaneous Coronary Intervention: A Pharmacogenomics Study
    Saydam, Faruk
    Degirmenci, Irfan
    Birdane, Alparslan
    Ozdemir, Mahmut
    Ulus, Taner
    Ozbayer, Cansu
    Colak, Ertugrul
    Ata, Necmi
    Gunes, Hasan Veysi
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2017, 121 (01) : 29 - 36
  • [10] Study on the effect of CYP2C19 genetic polymorphism and plasma concentration on clopidogrel resistance
    Wu, Hui
    Chen, Xinli
    Ding, Yongli
    Deng, Yanglin
    Ma, Ruilan
    Chen, Xinyuan
    Li, Xuesong
    PAKISTAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2021, 34 (05) : 1685 - 1691
12345